Linked Life Data

19809814

Source:http://linkedlifedata.com/resource/pubmed/id/19809814

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19809814rdf:typepubmed:Citationlld:pubmed
pubmed-article:19809814lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:19809814lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:19809814lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:19809814lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:19809814lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:19809814lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:19809814lifeskim:mentionsumls-concept:C0012863lld:lifeskim
pubmed-article:19809814lifeskim:mentionsumls-concept:C0597298lld:lifeskim
pubmed-article:19809814lifeskim:mentionsumls-concept:C1419259lld:lifeskim
pubmed-article:19809814lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:19809814lifeskim:mentionsumls-concept:C0762659lld:lifeskim
pubmed-article:19809814pubmed:issue2lld:pubmed
pubmed-article:19809814pubmed:dateCreated2010-5-18lld:pubmed
pubmed-article:19809814pubmed:abstractTextRanBP2 is a small ubiquitin-like modifier ligase for DNA topoisomerase II (TopoII) and plays a role in maintaining chromosome stability by recruiting TopoII to centromeres during mitosis. Engineered-mice with low amounts of RanBP2 have been reported to form lung adenocarcinomas. Furthermore, in the murine embryonic fibroblasts, formation of chromatin bridges in anaphase, a distinctive feature of cells with impaired DNA decatenation by chemical inhibition of TopoII, has been reported. In this study, we tested whether the association between mRNA expression of the RanBP2 gene and chemosensitivity of a TopoII inhibitor, amrubicin could be seen.lld:pubmed
pubmed-article:19809814pubmed:languageenglld:pubmed
pubmed-article:19809814pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:citationSubsetIMlld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19809814pubmed:statusMEDLINElld:pubmed
pubmed-article:19809814pubmed:monthJullld:pubmed
pubmed-article:19809814pubmed:issn1432-0843lld:pubmed
pubmed-article:19809814pubmed:authorpubmed-author:OsadaHirotaka...lld:pubmed
pubmed-article:19809814pubmed:authorpubmed-author:SekidoYoshita...lld:pubmed
pubmed-article:19809814pubmed:authorpubmed-author:HidaToyoakiTlld:pubmed
pubmed-article:19809814pubmed:authorpubmed-author:HorioYoshitsu...lld:pubmed
pubmed-article:19809814pubmed:authorpubmed-author:ShimizuJunich...lld:pubmed
pubmed-article:19809814pubmed:authorpubmed-author:OgawaShizuSlld:pubmed
pubmed-article:19809814pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19809814pubmed:volume66lld:pubmed
pubmed-article:19809814pubmed:ownerNLMlld:pubmed
pubmed-article:19809814pubmed:authorsCompleteYlld:pubmed
pubmed-article:19809814pubmed:pagination237-43lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:meshHeadingpubmed-meshheading:19809814...lld:pubmed
pubmed-article:19809814pubmed:year2010lld:pubmed
pubmed-article:19809814pubmed:articleTitleRelationship of mRNA expressions of RanBP2 and topoisomerase II isoforms to cytotoxicity of amrubicin in human lung cancer cell lines.lld:pubmed
pubmed-article:19809814pubmed:affiliationDepartment of Thoracic Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan. yhorio@aichi-cc.jplld:pubmed
pubmed-article:19809814pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19809814pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed